• Ajoutez une description, des images, des menus et des liens à votre méga-menu

  • Une colonne sans paramètres peut être utilisée comme un espaceur

  • Lien vers vos collections, vos ventes et même des liens externes

  • Ajoutez jusqu'à cinq colonnes

  • octobre 28, 2016 2 lire la lecture

    About 1 in 4 people in Swaziland are infected with HIV, so preventing mother-to-child transmission (PMTCT) is an essential strategy in reducing the country’s burden of HIV/AIDS. To achieve this however, pediatricians working in Swaziland and other low income settings underscored the need for a simple tool to enhance the dosing accuracy of liquid antiretroviral (ARV) regimens.

    In response, undergraduates at [Rice 360º](http://www.rice360.rice.edu/), the prolific Institute for Global Health Technologies at Rice University, developed the [DoseRight™ Syringe Clip](http://cohesion.rice.edu/collaborations/btb/emplibrary/DoseRight%20Syringe%20Clip.pdf). These color-coded, low-cost clips are inserted into an oral dosing syringe, limiting the amount of liquid that is dispensed and dramatically increasing the likelihood of accurate dosing. Using DoseRight™, mothers can effectively administer ARVs to themselves and their children.

    We’ve featured some of Rice 360º’s global health technologies in our Innovation Index, including the [salad spinner centrifuge](http://maternova.net/health-innovations/salad-spinner-centrifuge-anemia) and the [OB/GYN Lab-in-a-Backpack](http://maternova.net/health-innovations/obgyn-lab-backpack). However, what distinguishes the DoseRight™ clip is the way this technology was so rapidly deployed at the national level. In August, Swaziland’s Ministry of Health began distributing more than 200,000 dosing clips as part of its PMTCT Program.

    This is the largest rollout yet of a global health technology developed by Rice 360º’s undergraduate students, who were also instrumental in securing DoseRight™’s [nationwide dissemination](http://cohesion.rice.edu/collaborations/btb/emplibrary/CGI_Poster_Final.pdf). Rice students worked for two years to build an alliance among the Swazi Ministry of Health, the [Clinton Health Access Initiative](http://www.clintonfoundation.org/what-we-do/clinton-health-access-initiative), and [3rd Stone Design](http://doseright.com/index.html), which has facilitated the distribution, funding and manufacturing of the dosing clips.

    So many technologies stop at the student design stage despite extensive research and good links with a facility or Ministry in a low-income country. This is a terrific example of a full rollout that occurred quickly. Watch an [instructional video](http://doseright.com/3.html) or a video showcasing the clips on Rice 360º’s [website](http://www.rice360.rice.edu/content.aspx?id=826)!
    In April, former President [Bill Clinton](http://www.media.rice.edu/media/NewsBot.asp?MODE=VIEW&ID=15599&SnID=16780591) honored Rice students for their innovation in developing the clips and their dedication in achieving its swift uptake at the national level.

    Laisser un commentaire

    Les commentaires sont approuvés avant leur publication.


    Voir l'article entier

    Medical Devices for Hospitals and NGOs: How to Source the Right products for Maternal and Newborn Care
    Dispositifs médicaux pour les hôpitaux et les ONG : comment acheter les bons produits pour les soins maternels et néonatals

    juin 30, 2026 13 lire la lecture

    Voir l'article entier
    The High Quality Maternova Non-pneumatic anti-shock garment (NASG)
    Le vêtement antichoc non pneumatique (NASG) Maternova de haute qualité

    mai 25, 2026 1 lire la lecture

    Des vêtements antichoc non-pneumatiques (NASG) de haute qualité, conformes à la norme ISO 13485 et marqués CE, produits par Maternova pour être utilisés par les sages-femmes et les obstétriciens du monde entier afin de sauver des vies menacées par l'hémorragie post-partum. Nos NASG respectent les normes les plus strictes et sont approuvés par des centaines de cliniciens.

    Voir l'article entier
    A $.03 pill that could prevent maternal deaths; Part 4
    Une pilule à 0,03 $ qui pourrait prévenir les décès maternels ; 4ème partie

    mai 25, 2026 3 lire la lecture

    L'USPSTF, l'ACOG, la Society for Maternal-Fetal Medicine et la FIGO recommandent toutes l'aspirine à faible dose (LDA) pour les grossesses à haut risque. Les obstacles sont systémiques, comportementaux et structurels.

    Voir l'article entier